JP5015781B2 - 医薬用ジスルフィド塩 - Google Patents

医薬用ジスルフィド塩 Download PDF

Info

Publication number
JP5015781B2
JP5015781B2 JP2007532635A JP2007532635A JP5015781B2 JP 5015781 B2 JP5015781 B2 JP 5015781B2 JP 2007532635 A JP2007532635 A JP 2007532635A JP 2007532635 A JP2007532635 A JP 2007532635A JP 5015781 B2 JP5015781 B2 JP 5015781B2
Authority
JP
Japan
Prior art keywords
ions
formula
group
ion
represented
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP2007532635A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008513503A5 (enExample
JP2008513503A (ja
Inventor
チウリ ホアン,
ハリー コチャット,
シンハイ チェン,
Original Assignee
バイオニューメリック・ファーマスーティカルズ・インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by バイオニューメリック・ファーマスーティカルズ・インコーポレイテッド filed Critical バイオニューメリック・ファーマスーティカルズ・インコーポレイテッド
Publication of JP2008513503A publication Critical patent/JP2008513503A/ja
Publication of JP2008513503A5 publication Critical patent/JP2008513503A5/ja
Application granted granted Critical
Publication of JP5015781B2 publication Critical patent/JP5015781B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/64Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and sulfur atoms, not being part of thio groups, bound to the same carbon skeleton
    • C07C323/66Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and sulfur atoms, not being part of thio groups, bound to the same carbon skeleton containing sulfur atoms of sulfo, esterified sulfo or halosulfonyl groups, bound to the carbon skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/02Antidotes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2007532635A 2004-09-21 2005-09-21 医薬用ジスルフィド塩 Expired - Lifetime JP5015781B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/945,809 US7282602B2 (en) 2004-09-21 2004-09-21 Medicinal disulfide salts
US10/945,809 2004-09-21
PCT/US2005/033774 WO2006034327A1 (en) 2004-09-21 2005-09-21 Medicinal disulfide salts

Publications (3)

Publication Number Publication Date
JP2008513503A JP2008513503A (ja) 2008-05-01
JP2008513503A5 JP2008513503A5 (enExample) 2008-08-21
JP5015781B2 true JP5015781B2 (ja) 2012-08-29

Family

ID=36074969

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007532635A Expired - Lifetime JP5015781B2 (ja) 2004-09-21 2005-09-21 医薬用ジスルフィド塩

Country Status (7)

Country Link
US (1) US7282602B2 (enExample)
EP (1) EP1797031A4 (enExample)
JP (1) JP5015781B2 (enExample)
CN (1) CN101076513A (enExample)
CA (1) CA2580802C (enExample)
MX (1) MX2007003174A (enExample)
WO (1) WO2006034327A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011067653A1 (en) * 2009-12-04 2011-06-09 Carlo Ghisalberti Oral compositions for use in the mercury intoxication from dental amalgam
JP6271233B2 (ja) * 2013-11-29 2018-01-31 ローム・アンド・ハース電子材料株式会社 表面処理液
WO2015106240A1 (en) 2014-01-13 2015-07-16 The General Hospital Corporation Heteroaryl disulfide compounds as allosteric effectors for increasing the oxygen-binding affinity of hemoglobin
JP2023509985A (ja) * 2020-01-10 2023-03-10 ランタン ファルマ インコーポレイテッド 2,2’-ジチオ-ビス-エタンスルホン酸塩に対する感受性を決定する方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE593047A (enExample) * 1959-07-17
DE2025538A1 (de) * 1970-04-02 1971-10-21 Lokomotivbau Elektrotech Verfahren zur galvanischen Glanzverkupferung aus sauren Elektrolyten
BE788685A (nl) * 1971-09-13 1973-03-12 Agfa Gevaert Nv Ontwikkeling van contrastrijke zilverhalogenide-emulsies voor grafischedoeleinden
DD122086A1 (enExample) * 1975-06-16 1976-09-12
IT1185551B (it) * 1985-04-15 1987-11-12 Schering Spa Composizioni farmaceutiche a base di acido mercaptoetansolfonico ad attivita' terapeutica,derivati salini organici dell'acido mercaptoetansolfonico utili per tali composizioni e relativo procedimento di preparazione
DE4032864A1 (de) * 1990-10-13 1992-04-16 Schering Ag Saures bad zur galvanischen abscheidung von kupferueberzuegen und verfahren unter verwendung dieser kombination
DE4127821A1 (de) * 1991-08-23 1993-02-25 Basf Ag Disulfide, verfahren zu deren herstellung und deren verwendung
US5789000A (en) * 1994-11-14 1998-08-04 Bionumerik Pharmaceuticals, Inc. Sterile aqueous parenteral formulations of cis-diammine dichloro platinum
US5661188A (en) * 1995-06-07 1997-08-26 Medical Research Foundation and Infrastructure Development for Health Services--Nahariya Hospital Branch Therapeutic uses for sodium 2-mercaptoethanesulphonate (mesna)
CA2263166C (en) * 1996-09-23 2006-12-12 Bionumerik Pharmaceuticals, Inc. Reducing toxic effects of carboplatin using dithioethers
ES2163197T3 (es) * 1996-10-01 2002-01-16 Bionumerik Pharmaceuticals Inc Procedimiento para producir ditiobis-alcanosulfonatos y fosfonatos.
US6160167A (en) * 1998-04-21 2000-12-12 Bionumerik Pharmaceuticals, Inc. Mercaptans and disulfides
JP3124523B2 (ja) * 1999-01-28 2001-01-15 日本エレクトロプレイテイング・エンジニヤース株式会社 銅メッキ方法
KR20020029626A (ko) * 2000-10-13 2002-04-19 마티네즈 길러모 전해질
JP2003072231A (ja) * 2001-09-06 2003-03-12 Oji Paper Co Ltd インクジェット記録用シート
US6504049B1 (en) * 2002-04-30 2003-01-07 Bionumerik Pharmaceuticals, Inc. Process for synthesizing pharmaceutically active disulfide salts
KR100598994B1 (ko) * 2002-12-25 2006-07-07 닛코킨조쿠 가부시키가이샤 특정골격을 갖는 4급아민화합물 중합체 및 유기유황화합물을 첨가제로서 포함하는 동전해액 및 그것에 의하여 제조되는 전해동박
JP2005048256A (ja) * 2003-07-30 2005-02-24 Asahi Denka Kogyo Kk 銅メッキ用添加剤、銅メッキ浴および銅メッキ方法
JP2006104134A (ja) * 2004-10-06 2006-04-20 Asahi Denka Kogyo Kk ジスルフィド類の製造方法
JP4750486B2 (ja) * 2005-07-06 2011-08-17 株式会社Adeka 電解銅メッキ用添加剤、該添加剤を含有する電解銅メッキ浴及び該メッキ浴を使用する電解銅メッキ方法

Also Published As

Publication number Publication date
MX2007003174A (es) 2008-01-11
US20060063949A1 (en) 2006-03-23
EP1797031A1 (en) 2007-06-20
US7282602B2 (en) 2007-10-16
CA2580802A1 (en) 2006-03-30
WO2006034327A1 (en) 2006-03-30
JP2008513503A (ja) 2008-05-01
CA2580802C (en) 2012-11-20
EP1797031A4 (en) 2009-12-16
CN101076513A (zh) 2007-11-21

Similar Documents

Publication Publication Date Title
FI108034B (fi) Menetelmä terapeuttisesti tai profylaktisesti käyttökelpoisten guanidiinialkyyli-1,1-bisfosfonihappojohdannaisten valmistamiseksi
Tammara et al. Morpholinoalkyl ester prodrugs of diclofenac: synthesis, in vitro and in vivo evaluation
DE69026964T2 (de) Gem-diphosphonsäuren, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
US6160167A (en) Mercaptans and disulfides
JP4478561B2 (ja) 薬学的に活性なジスルフィド塩の合成方法
JP5015781B2 (ja) 医薬用ジスルフィド塩
KR100396036B1 (ko) 골다공증 치료를 위한 디포스폰산 염
JPH04352789A (ja) ガリウム化合物
US6265437B1 (en) Aminoalkanesulphonic acid derivatives, their preparation and their use as medicaments
JP4936898B2 (ja) ジスルフィド類の合成方法
FI111074B (fi) Menetelmä nitraattoalkaanikarboksyylihappojohdannaisten valmistamiseksi
EP2235022B1 (en) Dimeric derivatives of artemisinin and application in anticancer therapy
FR2640269A1 (fr) Composes organometalliques, leurs modes de preparation et compositions pharmaceutiques les contenant
JP2019518029A5 (enExample)
JPH054951A (ja) 1,4−ジヒドロナフトキノン誘導体およびその製造方法
KR900006124B1 (ko) Gem-디할로 및 테트라할로-1,12-디아미노-4,9-디아자-도데칸 및 이들의 제조방법
FR2525221A1 (fr) Derives du furanne et sels d'addition de ces derives, leurs procedes de preparation et leurs applications en therapeutique
JPS59190998A (ja) 新規ビス(2,2−ジメチル−1−アジリジニル)ホスフインアミド類及びその腫瘍阻止組成物
EP1196371B1 (fr) Precurseurs de sels de bis-ammonium quaternaire et leurs applications comme prodrogues ayant une activite anti-parasitaire
CA2584083A1 (fr) Nouveaux sels de strontium d'acides sulfoniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP0254167B1 (en) 1-hydroxy-5-oxo-5h-pyrido(3,2-a)-phenoxazine-3-carboxylic acid esters
FR2572730A1 (fr) Nouveaux derives de l'arsenic, leur preparation et leur application, notamment comme medicaments antiparasitaires
RU2015964C1 (ru) Способ получения замещенных производных амина
KR980009255A (ko) 간장질환 치료 및 예방에 유용한 화합물의 신규 유기염류 및 그 제조방법

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080703

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20080703

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20110525

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110607

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20110705

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20110712

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20111206

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120124

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120423

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20120529

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20120607

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20150615

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Ref document number: 5015781

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250